{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:41:32Z","timestamp":1762875692854},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T00:00:00Z","timestamp":1429488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.aprim.2015.02.010","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T19:57:20Z","timestamp":1433620640000},"page":"95-101","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Estudio observacional prospectivo con insulina detemir en pacientes con diabetes mellitus tipo 2 mal controlados que inician por primer vez tratamiento con insulina (estudio SOLVE)"],"prefix":"10.1016","volume":"48","author":[{"given":"Domingo","family":"Orozco-Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Artola-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2015.02.010_bib0145","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2015.02.010_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2015.02.010_bib0155","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2015.02.010_bib0160","first-page":"202","article-title":"Recommendations for the pharmacological treatment of hyperglycemia in type2 diabetes","volume":"43","author":"Menendez Torre","year":"2011","journal-title":"Aten Primaria."},{"issue":"Suppl 1","key":"10.1016\/j.aprim.2015.02.010_bib0165","first-page":"S11","article-title":"Standards of edical care in diabetes\u20142013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aprim.2015.02.010_bib0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2015.02.010_bib0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1464-5491.2005.01778.x","article-title":"Measuring beliefs about taking hypoglycaemic medication among people with type2 diabetes","volume":"23","author":"Farmer","year":"2006","journal-title":"Diabet Med."},{"key":"10.1016\/j.aprim.2015.02.010_bib0180","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2165\/11470200-000000000-00000","article-title":"Insulin detemir: A review of its use in the management of diabetes mellitus","volume":"72","author":"Keating","year":"2012","journal-title":"Drugs."},{"key":"10.1016\/j.aprim.2015.02.010_bib0185","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-007-0911-x","article-title":"A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type2 diabetes","volume":"51","author":"Rosenstock","year":"2008","journal-title":"Diabetologia."},{"key":"10.1016\/j.aprim.2015.02.010_bib0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000149569","article-title":"Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetes","volume":"82","author":"Fakhoury","year":"2008","journal-title":"Pharmacology."},{"key":"10.1016\/j.aprim.2015.02.010_bib0195","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1463-1326.2012.01665.x","article-title":"The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type2 diabetes in a clinical practice setting in 10 countries","volume":"14","author":"Khunti","year":"2012","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.aprim.2015.02.010_bib0200","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1758-5996-5-56","article-title":"Initiation of once daily insulin detemir is not associated with weight gain in patients with type2 diabetes mellitus: Results from an observational study","volume":"5","author":"Yale","year":"2013","journal-title":"Diabetol Metab Syndr."},{"key":"10.1016\/j.aprim.2015.02.010_bib0205","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1463-1326.2006.00677.x","article-title":"PREDICTIVE \u2014 a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: Baseline characteristics and predictors of hypoglycaemia from the European cohort","volume":"9","author":"Luddeke","year":"2007","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.aprim.2015.02.010_bib0210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1742-1241.2008.01715.x","article-title":"Insulin detemir improves glycaemic control without weight gain in insulin-naive patients with type2 diabetes: Subgroup analysis from the PREDICTIVE study","volume":"62","author":"Dornhorst","year":"2008","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.aprim.2015.02.010_bib0215","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1463-1326.2006.00674.x","volume":"9","author":"Meneghini","year":"2007","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.aprim.2015.02.010_bib0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1463-1326.2009.01060.x","article-title":"Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: An assessment of two different fasting plasma glucose targets \u2014 the TITRATE study","volume":"11","author":"Blonde","year":"2009","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.aprim.2015.02.010_bib0225","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1463-1326.2010.01351.x","article-title":"Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: The TRANSITION randomized controlled trial","volume":"13","author":"Hollander","year":"2011","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.aprim.2015.02.010_bib0230","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.clinthera.2006.10.020","article-title":"Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type2 diabetes","volume":"28","author":"Philis-Tsimikas","year":"2006","journal-title":"Clin Ther."},{"issue":"Suppl 4","key":"10.1016\/j.aprim.2015.02.010_bib0235","first-page":"102","article-title":"Once daily insulin detemir in patients with type2 diabetes: Results of German centers in a 6-month international observational study (SOLVE)","volume":"154","author":"Liebl","year":"2012","journal-title":"MMW Fortschr Med"},{"key":"10.1016\/j.aprim.2015.02.010_bib0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pcd.2013.11.010","article-title":"Results from the UK cohort of SOLVE: Providing insights into the timing of insulin initiation in people with poorly controlled type2 diabetes in routine clinical practice","volume":"8","author":"Khunti","year":"2014","journal-title":"Prim Care Diabetes."},{"key":"10.1016\/j.aprim.2015.02.010_bib0245","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1463-1326.2012.01602.x","article-title":"Study of Once Daily Levemir (SOLVE): Insights into the timing of insulin initiation in people with poorly controlled type2 diabetes in routine clinical practice","volume":"14","author":"Khunti","year":"2012","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.aprim.2015.02.010_bib0250","first-page":"377","article-title":"Inertia and treatment compliance in patients with type2 diabetes in primary care","volume":"138","author":"Lopez-Simarro","year":"2012","journal-title":"Med Clin (Barc)."},{"issue":"Suppl 1","key":"10.1016\/j.aprim.2015.02.010_bib0255","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/S0168-8227(11)70022-5","article-title":"Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type2","volume":"93","author":"Pagkalos","year":"2011","journal-title":"Diabetes Res Clin Pract."},{"issue":"Suppl 2","key":"10.1016\/j.aprim.2015.02.010_bib0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1745-7599.2012.00721.x","article-title":"Insulin initiation in type2 diabetes: What are the treatment regimen options and how can we best help patients feel empowered?","volume":"24","author":"Spollett","year":"2012","journal-title":"J Am Acad Nurse Pract."},{"issue":"Suppl 1","key":"10.1016\/j.aprim.2015.02.010_bib0265","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S1751-9918(10)60008-3","article-title":"Practical guidance to insulin management","volume":"4","author":"Meneghini","year":"2010","journal-title":"Prim Care Diabetes."},{"key":"10.1016\/j.aprim.2015.02.010_bib0270","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/ijcp.12160","article-title":"Barriers associated with poor control in Spanish diabetic patients. A consensus study","volume":"67","author":"Carratala-Munuera","year":"2013","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.aprim.2015.02.010_bib0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/DMSO.S26980","article-title":"Insulin detemir for the treatment of obese patients with type 2 diabetes","volume":"5","author":"Hollander","year":"2012","journal-title":"Diabetes Metab Syndr Obes."},{"key":"10.1016\/j.aprim.2015.02.010_bib0280","first-page":"27","article-title":"Detemir as a once-daily basal insulin in type 2 diabetes","volume":"3","author":"Nelson","year":"2011","journal-title":"Clin Pharmacol."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656715001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656715001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T21:52:59Z","timestamp":1537566779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656715001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0212656715001225"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2015.02.010","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estudio observacional prospectivo con insulina detemir en pacientes con diabetes mellitus tipo 2 mal controlados que inician por primer vez tratamiento con insulina (estudio SOLVE)","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2015.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}